Kinase modulators for the treatment of cancer

US9416123B2 · kind B2 · utility

Assignee

• SYNOVO GMBH · DE

Inventors

• Michael Burnet · Bingen, DE
• Bassam Abu Thaher · Cairo, EG
• Jan Ehlert · Ehrenkirchen, DE
• Michael Kubbutat · Schallstadt, DE
• Christoph Schaechtele · Glückstadt, DE
• Frank Totzke · Glückstadt, DE

Key dates

• Filing date: Mar 28, 2014
• Grant date: Aug 16, 2016
• Expiry date: Mar 28, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the substituted pyrazole class as treatments for cancer are reported. A method of treating cancer in which a compound that inhibits the activity of receptor kinases. Said method is effective and can be provided in addition to standard therapies, notably chemotherapy using cytotoxic drugs and other forms of immune therapy including therapeutic vaccines.